BackNeogen Overview
Neogen Corp.

Neogen Target Price

Where could NEOG trade next? Consensus target price: $14.

Get informed when a big investor buys or sells

+ Follow

Share Price

$12.15

Average Target Price

$13.5011.1% upside

2 analysts in the last 4 months

High: $14 | Low: $13

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-30Guggenheim$1415.2% upsideOpen
2026-08-03Piper Sandler$137% upsideOpen
2026-01-12Piper SandlerDavid Westenberg$1017.7% downsideOpen
2026-01-09Guggenheim$121.2% downsideOpen
2025-10-16Piper SandlerDavid Westenberg$6.546.5% downsideOpen
2025-04-22Piper SandlerDavid Westenberg$558.8% downsideOpen
2024-08-06Piper SandlerDavid Westenberg$17.544% upsideOpen
2022-12-14Piper SandlerDavid Westenberg$1739.9% upsideOpen
2022-10-09Piper SandlerDavid Westenberg$1415.2% upsideOpen

Neogen (NEOG) FAQ

Neogen posts a target price of $14. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $14 for NEOG means covering analysts, on average, see the stock 11.1% upside of $12.15 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for NEOG's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Neogen's other metric pages and overview cover the third.

Judging Neogen against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $14 here, then scan peer and history charts to see if the gap is persistent.